A Phase II Study Assessing the Efficacy of Etoposide Free Chemotherapy Plus Durvalumab (MEDI4736) in First Line Extensive Disease Small Cell Lung Cancer (SCLC)

Condition:   Small Cell Lung Cancer Extensive Stage Intervention:   Drug: Carboplatin + Paclitaxel + Durvalumab Sponsor:   Intergroupe Francophone de Cancerologie Thoracique Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials